![Scott Rocklage](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Rocklage
Presidente presso Halio, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Guido Magni | M | 70 |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| 5 anni |
Marina Udier | M | - |
Nouscom Srl
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 8 anni |
Alan Watt | M | - |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | - |
Paul Stone | M | 60 |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 15 anni |
Elisa Scarselli | F | - |
Nouscom Srl
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 anni |
Jeffrey Stein | M | 69 | 10 anni | |
Andrew Schwab | M | 53 |
5AM Partners III LLC
5AM Partners II LLC
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 22 anni |
Klint Rose | M | - |
Purigen Biosystems, Inc.
![]() Purigen Biosystems, Inc. BiotechnologyHealth Technology Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA. | 12 anni |
Rebecca Lucia | F | 52 |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 8 anni |
Richard Peters | M | 61 | 4 anni | |
Matthew D. Disney | M | - |
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | - |
John McDonald | M | 63 |
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| 6 anni |
Renato T. Skerlj | M | - |
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | 4 anni |
Galya Blachman | M | 47 |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 6 anni |
Daniel Burgess | M | 62 | 10 anni | |
John Henneman | M | 62 |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | 5 anni |
Michael Higgins | M | 61 | 9 anni | |
Michelle Ho | F | - |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 6 anni |
Deborah Palestrant | M | - |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 6 anni |
Leslie Tari | M | 57 | 11 anni | |
Kevin Lee | M | 55 |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | 6 anni |
Richard Davis | M | 51 |
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 4 anni |
Britt Inga Emerson | M | - |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 11 anni |
Paula Soteropoulos | F | 56 |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 4 anni |
Howard Turner | M | - |
Halio, Inc.
![]() Halio, Inc. Industrial SpecialtiesProcess Industries Halio, Inc. engages in the development of adaptive glass for the commercial, residential, and automotive markets. It builds products based on dynamic light control technology for connected home, offices, cars and other future applications. The firm also develops technologies applied to building materials for energy efficiency. The company was founded by Howard Turner and Sam Bergh in 2010 and is headquartered in South San Francisco, CA. | 14 anni |
Sam Bergh | M | - |
Halio, Inc.
![]() Halio, Inc. Industrial SpecialtiesProcess Industries Halio, Inc. engages in the development of adaptive glass for the commercial, residential, and automotive markets. It builds products based on dynamic light control technology for connected home, offices, cars and other future applications. The firm also develops technologies applied to building materials for energy efficiency. The company was founded by Howard Turner and Sam Bergh in 2010 and is headquartered in South San Francisco, CA. | 14 anni |
Jean-Paul Prieels | M | 78 |
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
Jessica Alfano | F | - |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 4 anni |
Kush Parmar | M | 42 |
Novira Therapeutics LLC
![]() Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA.
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 14 anni |
Genghis Lloyd-Harris | M | 67 |
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
Joseph J. Victor | M | - |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.
Purigen Biosystems, Inc.
![]() Purigen Biosystems, Inc. BiotechnologyHealth Technology Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA. | 18 anni |
Cinzia Traboni | M | - |
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 anni |
Chrysa Mineo | F | 59 | 6 anni | |
Henrijette Richter | M | 53 |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | - |
Mason W. Freeman | M | 73 |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 17 anni |
John Diekman | M | 81 |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 22 anni |
Jamil M. Beg | M | - |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | 7 anni |
Göran Albert Ando | M | 75 |
Nouscom Srl
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 4 anni |
Theodore Schroeder | M | 69 | 10 anni | |
Gary Bridger | M | 61 |
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | 2 anni |
Joachim Rothe | M | - |
Nouscom Srl
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
Allison Lewis | F | - | 9 anni | |
Alison Strutt | F | - |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | - |
Laura Tadvalkar | F | - |
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | 3 anni |
Bernd Seizinger | M | 67 |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | 9 anni |
Dipender Saluja | M | 59 |
Halio, Inc.
![]() Halio, Inc. Industrial SpecialtiesProcess Industries Halio, Inc. engages in the development of adaptive glass for the commercial, residential, and automotive markets. It builds products based on dynamic light control technology for connected home, offices, cars and other future applications. The firm also develops technologies applied to building materials for energy efficiency. The company was founded by Howard Turner and Sam Bergh in 2010 and is headquartered in South San Francisco, CA. | - |
Jean-François Marcel Heris | M | - |
Halio, Inc.
![]() Halio, Inc. Industrial SpecialtiesProcess Industries Halio, Inc. engages in the development of adaptive glass for the commercial, residential, and automotive markets. It builds products based on dynamic light control technology for connected home, offices, cars and other future applications. The firm also develops technologies applied to building materials for energy efficiency. The company was founded by Howard Turner and Sam Bergh in 2010 and is headquartered in South San Francisco, CA. | 7 anni |
Liz Roper | M | - |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | - |
Samuel D. Colella | M | 84 |
Halio, Inc.
![]() Halio, Inc. Industrial SpecialtiesProcess Industries Halio, Inc. engages in the development of adaptive glass for the commercial, residential, and automotive markets. It builds products based on dynamic light control technology for connected home, offices, cars and other future applications. The firm also develops technologies applied to building materials for energy efficiency. The company was founded by Howard Turner and Sam Bergh in 2010 and is headquartered in South San Francisco, CA. | - |
Andrew Phillips | M | 53 |
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | - |
Taylor Sandison | M | 52 | 9 anni | |
Alexander Pasteur | M | 54 |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | 6 anni |
Raidy Kevin J. | M | 55 |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | - |
Vincent Brichard | M | - |
Nouscom Srl
| - |
Donald Nicholson | M | 67 |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | 5 anni |
Elizabeth Ann Roper | M | 50 |
NodThera Ltd.
![]() NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | 8 anni |
Beth Seidenberg | M | 67 |
Expansion Therapeutics, Inc.
![]() Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | 6 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Christian Schade | M | 63 |
Novira Therapeutics LLC
![]() Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA.
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | 9 anni |
J. Judice | M | 61 | 13 anni | |
Kenneth Hillan | M | 63 | 8 anni | |
Amit Munshi | M | 56 | 9 anni | |
Michael Wyand | M | 68 | 4 anni | |
Matthew Onaitis | M | 53 | 2 anni | |
Jay Shepard | M | 66 | 3 anni | |
John C. Doyle | M | 55 | 10 anni | |
Gerrit Klaerner | M | 53 | 6 anni | |
Bryan Roberts | M | 57 | 15 anni | |
Johan Rutger Christenson | M | 65 |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | - |
Dennis Hom | M | 48 | 1 anni | |
Scott Coiante | M | 57 |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | 4 anni |
Osvaldo Flores | M | - |
Novira Therapeutics LLC
![]() Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | 6 anni |
Mark Iwicki | M | 57 | 6 anni | |
John Orwin | M | 59 | 4 anni | |
Gregory Korbel | M | 48 |
Novira Therapeutics LLC
![]() Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | 11 anni |
William Duke | M | 51 | 4 anni | |
Jon B. Bruss | M | - | - | |
Zeryn Sarpangal | F | 44 | 10 anni | |
Alan Colowick | M | 61 | 2 anni | |
Jessica Oien | F | 53 | 3 anni | |
Geoff Duyk | M | 64 | 2 anni | |
Wilhelm Stahl | M | 64 | 6 anni | |
Dan Spiegelman | M | 65 | 2 anni | |
Christopher Boerner | M | 53 | 1 anni | |
George Tyson | M | - | - | |
Paul Hastings | M | 64 | 4 anni | |
Julie McHugh | F | 59 | 2 anni | |
Huang I-Zu | M | - | - | |
Jonathan Hepple | M | 53 | 5 anni | |
Ronald A. Krasnow | M | 61 | - | |
John Smither | M | 71 | 7 anni | |
Kent E. Lieginger | M | 72 | - | |
David McGirr | M | 69 | 3 anni | |
Timothy Franson | M | 72 | 9 anni | |
John Butler | M | 59 | 3 anni | |
Camille Samuels | F | 52 | 11 anni | |
Jerry M. Buysse | M | 68 | 6 anni | |
Detlef F. Albrecht | M | 63 | - | |
Steven Elms | M | 60 | 1 anni | |
Claire J. Lockey | F | 71 | 5 anni | |
Mike Burdick | M | - | 4 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 80 | 80.00% |
Svizzera | 10 | 10.00% |
Italia | 9 | 9.00% |
Regno Unito | 9 | 9.00% |
Svezia | 6 | 6.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Scott Rocklage
- Contatti personali